Amgen reported progress across its KRAS inhibitor portfolio, including Lumakras and next generation candidates such as AMG 410. The company completed a Phase 3 study for Opdivo biosimilar ABP 206, a ...

Amgen Inc. (NASDAQ:AMGN) is one of the 10 best stocks to invest in during a recession. On February 27, 2026, Amgen Inc.

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

These stocks can be slow-and-steady wealth compounders.

Bristol Myers BMY is banking on its growth portfolio, which comprises Opdivo, Orencia, Yervoy, Reblozyl, Opdualag, Abecma, ...

Induction Yervoy (ipilimumab) plus Opdivo (nivolumab) followed by consolidative chemoradiotherapy demonstrated bladder ...

From today, thousands more Australians living with advanced and rare cancers will have access to affordable immunotherapy treatment options through ...

The stock is roughly 25% below its late 2022 highs, which is part of the attraction. There's still some recovery opportunity ...

More than 5000 Australians struggling with rare and advanced cancers will be able to access two new immunotherapy drugs for ...

Antonio Ocejo, MD, discussed a multi-institutional analysis focusing on the clinical outcomes and tolerability of ipilimumab ...

At its current valuation, Bristol Myers Squibb stock seems worthy of your attention. Pharmaceutical companies spend a ton of ...

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives.